|
We are internally focused on using our technologies to develop and commercialize proprietary RNAi and small molecule therapeutics. Calando's proprietary technologies have applications well beyond our capacity to develop internally. Consequently, we continually seek additional partnerships to advance the development of our technologies.
PARTNERSHIP OPPORTUNITIES
Calando is seeking additional strategic collaborations with pharmaceutical and biotechnology companies whose products or proprietary development compounds might benefit from Calando's technologies and expertise. Interested parties should contact James Hamilton at
626.683.7200 jhamilton@calandopharma.com
|
